Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,602 | -11,335 | -7,374 | -3,799 | -7,711 |
| Depreciation Amortization | N/A | 155 | N/A | N/A | 8 |
| Accounts receivable | N/A | N/A | N/A | -18 | -306 |
| Accounts payable and accrued liabilities | N/A | N/A | -1,221 | -1,000 | N/A |
| Other Working Capital | 1,643 | -128 | -981 | -1,494 | 1,583 |
| Other Operating Activity | 1,148 | 24 | 1,379 | 1,145 | 522 |
| Operating Cash Flow | $-14,811 | $-11,284 | $-8,197 | $-5,166 | $-5,904 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 3 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100,303 | 98,477 | 8,011 | 8,011 | 14,193 |
| Other Financing Activity | -433 | 1,326 | -222 | -88 | -624 |
| Financing Cash Flow | $99,870 | $99,803 | $7,789 | $7,923 | $13,569 |
| Beginning Cash Position | 9,792 | 9,792 | 9,792 | 9,792 | 2,124 |
| End Cash Position | 94,851 | 98,311 | 9,384 | 12,549 | 9,792 |
| Net Cash Flow | $85,059 | $88,519 | $-408 | $2,757 | $7,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,811 | -11,284 | -8,197 | -5,166 | -5,904 |
| Free Cash Flow | -14,811 | -11,284 | -8,197 | -5,166 | -5,904 |